Dectova 10 mg/mL solution for infusion clinical trials

An open label, single arm study to evaluate single and multiple dose pharmacokinetics, safety and tolerability, and to explore clinical outcomes of treatment with intravenous (IV) zanamivir in neonates and infants under 6 months of age with confirmed complicated influenza infection.

This study is looking at a medicine called zanamivir, given through a drip, for babies under 6 months old who have severe flu. We want to understand how the medicine works in their bodies and if it helps them get better. It's an early-stage study to see if it's safe and effective for these very young children.